BioVersys Stock

BioVersys is a privately held Swiss biopharmaceutical company.

Sign up today and learn more about BioVersys Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About BioVersys Stock

Bioversys AG is a privately held Swiss biopharmaceutical company located in Basel that focuses on research and development of new drugs and compounds, which switch-off drug resistance within bacterial pathogens and restore the efficacy of approved antibiotics. Spun out of the ETH-Zurich in 2008, we have profound technological expertise that is based on solid IP.

Funding History

May 2008$10K
September 2008$20K
May 2009$100K
March 2011$2.5M
November 2017$5.0M
October 2019$8.0M
September 2020$19.0M
April 2021$20.0M
June 2021$4.3M
June 2022$24.2M
January 2023$8.4M



Sergio Lociuro

Chairman of the Board

Seng Chin Mah

Board Member

Carly Levine

CEO & Co-Founder

Marc Gitzinger


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: